agilon health, inc. (AGL)
NYSE: AGL · Real-Time Price · USD
0.5893
-0.0053 (-0.89%)
At close: Feb 27, 2026, 4:00 PM EST
0.5867
-0.0026 (-0.44%)
After-hours: Feb 27, 2026, 7:53 PM EST

agilon health Statistics

Total Valuation

agilon health has a market cap or net worth of $244.48 million. The enterprise value is -$5.67 million.

Market Cap244.48M
Enterprise Value -5.67M

Important Dates

The last earnings date was Wednesday, February 25, 2026, after market close.

Earnings Date Feb 25, 2026
Ex-Dividend Date n/a

Share Statistics

agilon health has 414.87 million shares outstanding. The number of shares has increased by 0.73% in one year.

Current Share Class 414.87M
Shares Outstanding 414.87M
Shares Change (YoY) +0.73%
Shares Change (QoQ) +0.04%
Owned by Insiders (%) 1.47%
Owned by Institutions (%) 56.75%
Float 270.63M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.04
Forward PS 0.04
PB Ratio 1.93
P/TBV Ratio 4.01
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.02, with a Debt / Equity ratio of 0.28.

Current Ratio 1.02
Quick Ratio 0.89
Debt / Equity 0.28
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -64.32

Financial Efficiency

Return on equity (ROE) is -135.64% and return on invested capital (ROIC) is -78.91%.

Return on Equity (ROE) -135.64%
Return on Assets (ROA) -17.77%
Return on Invested Capital (ROIC) -78.91%
Return on Capital Employed (ROCE) -219.27%
Weighted Average Cost of Capital (WACC) 5.91%
Revenue Per Employee $5.51M
Profits Per Employee -$363,705
Employee Count1,076
Asset Turnover 3.95
Inventory Turnover n/a

Taxes

In the past 12 months, agilon health has paid $1.25 million in taxes.

Income Tax 1.25M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -82.46% in the last 52 weeks. The beta is 0.07, so agilon health's price volatility has been lower than the market average.

Beta (5Y) 0.07
52-Week Price Change -82.46%
50-Day Moving Average 0.71
200-Day Moving Average 1.25
Relative Strength Index (RSI) 50.49
Average Volume (20 Days) 9,216,207

Short Selling Information

The latest short interest is 20.41 million, so 4.92% of the outstanding shares have been sold short.

Short Interest 20.41M
Short Previous Month 20.41M
Short % of Shares Out 4.92%
Short % of Float 7.54%
Short Ratio (days to cover) 2.57

Income Statement

In the last 12 months, agilon health had revenue of $5.93 billion and -$391.35 million in losses. Loss per share was -$0.95.

Revenue5.93B
Gross Profit -160.02M
Operating Income -427.15M
Pretax Income -404.10M
Net Income -391.35M
EBITDA -398.56M
EBIT -427.15M
Loss Per Share -$0.95
Full Income Statement

Balance Sheet

The company has $285.14 million in cash and $34.99 million in debt, with a net cash position of $250.15 million or $0.60 per share.

Cash & Cash Equivalents 285.14M
Total Debt 34.99M
Net Cash 250.15M
Net Cash Per Share $0.60
Equity (Book Value) 126.73M
Book Value Per Share 0.31
Working Capital 20.21M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$105.76 million and capital expenditures -$13.24 million, giving a free cash flow of -$119.01 million.

Operating Cash Flow -105.76M
Capital Expenditures -13.24M
Free Cash Flow -119.01M
FCF Per Share -$0.29
Full Cash Flow Statement

Margins

Gross margin is -2.70%, with operating and profit margins of -7.20% and -6.60%.

Gross Margin -2.70%
Operating Margin -7.20%
Pretax Margin -6.81%
Profit Margin -6.60%
EBITDA Margin -6.72%
EBIT Margin -7.20%
FCF Margin n/a

Dividends & Yields

agilon health does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.73%
Shareholder Yield -0.73%
Earnings Yield -160.07%
FCF Yield -48.68%

Analyst Forecast

The average price target for agilon health is $2.68, which is 354.78% higher than the current price. The consensus rating is "Hold".

Price Target $2.68
Price Target Difference 354.78%
Analyst Consensus Hold
Analyst Count 14
Revenue Growth Forecast (5Y) 8.27%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2